Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 1991-07-01 (34 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: EPFIG (67680), Bas-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE ZINS : revenue, balance sheet and financial ratios
PHARMACIE ZINS is a French company
founded 34 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in EPFIG (67680),
this company of category PME
shows in 2025 a net income positive of 164 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE ZINS (SIREN 382907731)
Indicator
2025
2024
2023
2022
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
164 288 €
148 260 €
239 507 €
321 247 €
100 731 €
102 642 €
62 356 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE ZINS generates positive net income of 164 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 62 k€ -> 164 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
164 288 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 17%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
16.917%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
51.529%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2022
2023
2024
2025
Debt ratio
615.91
170.083
56.257
48.56
18.124
18.29
16.917
Financial autonomy
9.502
23.661
41.007
45.298
56.708
51.823
51.529
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
16.922025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good
In 2025, the debt ratio of PHARMACIE ZINS (16.92) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
51.53%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average-13 pts over 3 years
In 2025, the financial autonomy of PHARMACIE ZINS (51.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 140.17. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
140.167
Liquidity indicators evolution PHARMACIE ZINS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2022
2023
2024
2025
Liquidity ratio
95.653
101.831
88.548
199.625
183.675
149.098
140.167
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
140.172025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average-18 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE ZINS (140.17) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE ZINS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE ZINS is estimated at
2 609 734 €
(range 1 770 978€ - 4 095 032€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1770k€2609k€4095k€
2 609 734 €Range: 1 770 978€ - 4 095 032€
NAF 5 année 2025
Valuation method used
Net Income Multiple
164 288 €
×
15.9x
=2 609 734 €
Range: 1 770 978€ - 4 095 033€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ZINS with other companies in the same sector:
The revenue of PHARMACIE ZINS is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE ZINS profitable?
Yes, PHARMACIE ZINS generated a net profit of 164 k€ in 2025.
Where is the headquarters of PHARMACIE ZINS ?
The headquarters of PHARMACIE ZINS is located in EPFIG (67680), in the department Bas-Rhin.
Where to find the tax return of PHARMACIE ZINS ?
The tax return of PHARMACIE ZINS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ZINS operate?
PHARMACIE ZINS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart